The Victorian Comprehensive Cancer Centre Alliance, or VCCC Alliance for short, is a Victorian partnership of 10 research, academic and clinical institutions looking at improving cancer outcomes for patients:
- Peter MacCallum Cancer Centre
- The Royal Melbourne Hospital
- University of Melbourne
- The Royal Women’s Hospital
- WEHI
- The Royal Children’s Hospital
- Western Health
- St Vincent’s Hospital Melbourne and St Vincent’s Institute
- Austin Health and Olivia Newton-John Cancer Research Institute
- Murdoch Children’s Research Institute
The VCCC Alliance SKILLED clinical trial internships program is a pathway for scientists to build role-specific clinical trial knowledge, experience and in a clinical trials unit through theoretical and on-the-job training. The internship program is a 40 week intensive program to get science student interns job ready for clinical trial assistant and study coordinator internship roles.
The program is funded in part by MTPConnect’s $32 million REDI initiative, supported by the Medical Research Future Fund. Now into it’s 4th year, VCCC Alliance’s SKILLED Clinical Trials Internship program commenced in 2019 and by year end 2022 would have placed 77 interns into clinical trial units.
Australian Health Journal spoke with Chris Packer, Manager, SKILLED Clinical Trials Internship program at the VCCC Alliance about the need to build capacity of clinical trial units, especially with reductions on overseas travellers in the sector and other factors leading to gaps in the workforce.
In 2022, 22 intern have been placed in large tertiary facilities as well as in regional Victoria.
Australian Health Journal spoke with 2 recent interns about their experiences during and following the internship program:
- Dulash Fernando, Clinical Trials Assistant
- Rebecca Komesaroff, VCCC Skilled Intern (CTA)
Australian Health Journal also spoke to some of the host sites about the program and the important need to fill the clinical trial skills gap.
- Dr Sarah Rickard, Director Research Governance and Ethics, The Royal Melbourne Hospital
- Kate Scarff, Clinical Research Development Office Lead, Melbourne Children’s Trials Centre, Murdoch Children’s Research Institute
- Narelle McPhee, Cancer Research Manager, Bendigo Health
Narelle talks about the importance and uniqueness of the internship program for the staff in the Bendigo region. She sees the program as a strong partnership with VCCC Alliance, the intern and the clinical trials unit in Bendigo Health, that helps with future recruitment as well bringing new perspectives. There are opportunities in regional and rural locations undertaking clinical trials, and Narelle happily states, the interns they have previously hosted have gained employment in the region.
Internship evaluations by interns and the host sites in 2021 Net Promotor Scores (NPS) have shown high levels of satisfaction levels both from interns and host sites in the program. As further testament to its success, 95% of interns have gone back into the clinical trial sector since the commencement of the program.
Produced with assistance from:
ARCS Australia
-
Health Minister appoints Chair to National One Stop Shop Program
The Australian Government has appointed Emeritus Professor Ian Chubb AC, FAA FTSE to lead key reforms as Chair of the Inter-Governmental Policy Reform Group (IGPRG) for health and medical research, including clinical trials.
Minister for Health and Aged Care, The Hon Mark Butler MP on the selection and appointment said, “Professor Chubb has dedicated his career to improving health and medical research and education in this county and I am pleased he has agreed to share his knowledge and experience through the IGPRG.
-
World-first clinical trial improves patient outcomes for kidney transplants
A world-first clinical trial conducted at the Royal Adelaide Hospital (RAH) and at hospitals across Australia and New Zealand has identified the best fluid treatment to reduce the risk of patients requiring dialysis after a kidney transplant.
Australian Health Journal spoke with the lead-author of the study, RAH Nephrologist and University of Adelaide researcher, Dr Michael Collins.
-
Ensuring stringent quality standards in the lifecycle of medical devices
Dr Jasjit Baveja is the Associate Director of Policy at the Medical Technology Association of Australia (MTAA), where she oversees regulatory affairs, clinical code of practice, procurement, industry policy, reimbursement, and advocacy. With over 20 years of experience in the medical device regulatory space, Dr Bavej’s expertise lies in providing educational opportunities for regulatory professionals in Australia to ensure continuous learning and professional development. She collaborates closely with the Therapeutic Goods Administration (TGA) to run workshops that provide invaluable experience, networking opportunities, and skill enhancement.
